News

Let’s start with an introduction of sorts to CS McKee — your overall business, portfolios, and investment approach — before we get into a specific fund. Mr. Thompson: At CS McKee, we’re primarily an ...
I thought a good place to start would be with you, Craig, telling our readers a bit about Icon Advisers, the company overall and what the business looks like today. It’s almost 40 years ago that you ...
Introduce our readers to R5 Capital by telling us a bit about the business overall. Mr. Mushkin: R5 Capital is a consumer research and consulting firm. It was formed roughly five and a half years ago.
For our readers, let’s start with some introductory information about Phocas Financial, an overview of the firm’s history and what the business looks like today. Ms. Foreman: Phocas is an ...
Alan H. Auerbach has served as Chairman of the Board and as CEO and President of Puma Biotechnology, Inc. since its inception. Before joining Puma, Mr. Auerbach served as Founder, CEO, President ...
Steven M. Lichtman is Managing Director and Senior Analyst for medical devices at Oppenheimer & Co. Inc. Mr. Lichtman has been on the sell side following the medical devices sector for over 20 ...
Jason Wittes is a Managing Director and Senior Research Analyst at Roth Capital Partners. He has over 20 years of health care investment experience on both the buy side and sell side. Prior to ...
Cuong Do is President and CEO of BioVie Inc. Prior to his appointment with BioVie, Mr. Do was President of Samsung Global Strategy Group where he helped to set the strategic direction for Samsung ...
Vlad Vitoc, M.D., is Chairman of Board, Chief Executive Officer, and President of MAIA Biotechnology Inc. Dr. Vitoc has a broad array of experience across commercial strategic analysis and ...
Hartaj Singh is a Founding Partner of Tecumseh Partners, advising biotech companies on valuation, strategy, and investor engagement. He also writes The Biotech Capital Compass, a newsletter ...
Ilan Sobel has been the CEO of BioHarvest Sciences Inc. since July 2020. He brought the company’s first product, VINIA, to North America, building a direct-to-consumer machine that is now ...
The Wall Street Transcript is a completely unique resource for investors and business researchers.